close
Sucess

Great! You have sucessfully subscribed for newsletters for investments

Subscribed email:

Compare Mutual Funds

 
  • Category,
    Sub-category
  • equity, sectoral-pharma
  • equity, sectoral-pharma
  • ET Money Rank in sub-category
  • N.A.
  • N.A.
  • Fund Age
  • 3 yrs 9 m
  • 12 yrs 6 m
  • Fund Size
  • ₹221 Cr
  • ₹1,062 Cr
  • 3 months
  • 13.0%
  • 15.47%
  • 6 months
  • -3.7%
  • 0.19%
  • 1 year
  • 14.17%
  • 21.09%
  • 3 year
  • 24.24%
  • 28.57%
  • 5 year
  • NA
  • 23.83%
  • Standard Deviation
  • 15.42
  • 15.53
  • Sharpe
  • 1.07
  • 1.28
  • Beta
  • 0.95
  • 0.95
  • Sortino
  • 1.49
  • 1.97
  • Alpha
  • -2.12
  • 1.12
  • Top 3 sectors
    • Healthcare (93.84%)
    • Chemicals (3.6399999999999997%)
    • Services (1.29%)
    • Healthcare (97.34%)
  • Top 5 holdings
    • Sun Pharmaceutical Industries Ltd. (15.18%)
    • Divi's Laboratories Ltd. (9.12%)
    • Max Healthcare Institute Ltd. (5.42%)
    • Lupin Ltd. (5.4%)
    • Apollo Hospitals Enterprise Ltd. (5.19%)
    • Sun Pharmaceutical Industries Ltd. (10.44%)
    • Cipla Ltd. (5.52%)
    • Dr. Reddy's Laboratories Ltd. (4.66%)
    • Procter & Gamble Health Ltd. (4.34%)
    • Ajanta Pharma Ltd. (4.09%)
  • Equity%
  • 99.7%
  • 97.32995444%
  • Debt%
  • 0.0%
  • 0.01035594%
  • Turnover Ratio
  • NA
  • NA
  • Yield To Maturity
  • NA
  • NA
  • Modified Duration
  • NA
  • NA
  • Avg. Maturity
  • NA
  • NA
  • Avg. Credit Quality
  • NA
  • NA
  • Expense Ratio
  • 2.35%
  • 1.28%
  • Exit Load
  • 0.5% know more
  • 1.0% know more
  • Lock-in
  • No Lockin
  • No Lockin
  • Benchmark Index
  • NIFTY Healthcare TRI.
  • BSE Healthcare TRI
  • Min. Investment
  • NA
  • SIP ₹500 & Lumpsum ₹5000
  • Investment Horizon
  • Good for Long Term
  • Good for Long Term
  • Managed By
    • Rohan Korde
    • Dhimant Shah
    • Kamal Gada
Go to top